"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative ...

People with endometriosis could be given a new pill on the NHS which is said to be better than what's currently on offer.

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new pill that promises to help endometriosis sufferers deal with the chronic disease’s debilitating symptoms was approved ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The first-of-its-kind endometriosis pill provides hope for 1.5 million people in the UK affected by the condition ...